AstraZeneca (NYSE: AZN) has acquired a portfolio of neuroscience assets from Link Medicine Corporation, a privately held biopharmaceutical company based ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE